Walleye Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Walleye Trading’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,900	Closed	-$213K	–	5521
2016 Q3	$213K	Sell	12,900 -12,300	-49%	-$182K	﹤0.01%	2764
2016 Q2	$338K	Buy	25,200 +24,500	+3,500%	+$357K	﹤0.01%	2552
2016 Q1	$11K	Buy	+700	New	+$11K	﹤0.01%	4722
2015 Q4	–	Sell	-2,300	Closed	-$40K	–	6030
2015 Q3	$40K	Buy	2,300 +2,000	+667%	+$40.7K	﹤0.01%	3667
2015 Q2	$6K	Buy	+300	New	+$5.79K	﹤0.01%	4478
2015 Q1	–	Sell	-1,800	Closed	-$29K	–	4728
2014 Q4	$29K	Sell	1,800 -1,300	-42%	-$23.9K	﹤0.01%	3506
2014 Q3	$69K	Buy	3,100 +2,300	+288%	+$47.1K	﹤0.01%	2913
2014 Q2	$16	Buy	800 +600	+300%	+$10.2K	﹤0.01%	3290
2014 Q1	$4	Buy	+200	New	+$2.75K	﹤0.01%	3378

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Walleye Trading's AMRI Position: Q3 2017 in Review

Walleye Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 60,117 shares — an estimated $1.3K sold.

Walleye Trading first reported a position in AMRI in Q4 2013 and held it in 5 quarters. The position peaked at $181K in Q4 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Walleye Trading reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Walleye Trading sold 60,117 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.3K.
Walleye Trading first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 5 quarters.
Walleye Trading's Albany Molecular Research Inc position peaked at $181K in Q4 2015.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Walleye Trading's 13F filing for Q3 2017, filed 14 Nov 2017.